Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

12.5%

3 terminated/withdrawn out of 24 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

71%

17 trials in Phase 3/4

Results Transparency

43%

9 of 21 completed trials have results

Key Signals

9 with results

Enrollment Performance

Analytics

Phase 4
15(83.3%)
Phase 3
2(11.1%)
Phase 2
1(5.6%)
18Total
Phase 4(15)
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT00766402Phase 4Terminated

An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)

Role: lead

NCT00526877Phase 4Completed

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

Role: lead

NCT02268890Phase 4Completed

A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

Role: lead

NCT01670071Phase 4Terminated

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Role: lead

NCT00642564Completed

Study on Migraine and Headache in Epileptic Patients

Role: lead

NCT00771212Completed

Observational Study on the Patients With Pain Medications

Role: lead

NCT00641459Completed

A Study on Behavioral and Psychological Symptoms of Dementia

Role: lead

NCT00614861Completed

Pain Satisfaction Survey

Role: lead

NCT00644852Completed

Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

Role: lead

NCT00758160Phase 4Completed

The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Role: lead

NCT02075528Phase 4Completed

Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER

Role: collaborator

NCT00757705Phase 4Completed

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia

Role: lead

NCT01577186Phase 4Completed

Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)

Role: lead

NCT01577160Phase 4Completed

A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia

Role: lead

NCT01627860Phase 4Completed

First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients

Role: lead

NCT00744757Phase 2Completed

An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

Role: lead

NCT00803283Phase 3Terminated

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Role: lead

NCT00766675Phase 4Completed

An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain

Role: lead

NCT01801436Phase 3Completed

A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma

Role: lead

NCT00752635Phase 4Completed

Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

Role: lead